Definitions
from Wiktionary, Creative Commons Attribution/Share-Alike License.
- noun A particular
antipsoriatic drug .
Etymologies
from Wiktionary, Creative Commons Attribution/Share-Alike License
Support
Help support Wordnik (and make this page ad-free) by adopting the word efalizumab.
Examples
-
Raptiva, which is also known as efalizumab, is an immunosuppressant drug used to treat and prevent psoriasis, a chronic, non-contagious autoimmune disease which causes excess skin production and joint pain.
-
Raptiva, which is also known as efalizumab, is an immunosuppressant drug used to treat and prevent psoriasis, a chronic, non-contagious autoimmune disease which causes excess skin production and joint pain.
-
With regard to its psoriasis drug Raptiva efalizumab, a chain of unfortunate events began when Xoma's management at the time miscalculated the firm's financial capability with regard to co-developing this drug with Genentech.
Xoma and Elan: A Tale of Two Mismanaged Biotech Companies, Part 1 - Seeking Alpha 2011
-
Chamian F, Abello MV, Fuentes-Duculan J, Lin SL, et al. (2005) Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a).
PLoS ONE Alerts: New Articles Malgorzata Romanowska et al. 2010
-
Obstacles to Stelara adoption include concerns about long term safety which are exacerbated by the recent withdrawal of Genentech/Xoma's Raptiva (efalizumab) due to PML.
THE MEDICAL NEWS Editors 2010
-
Genentech estimated that approximately 2,000 patients in the United States may currently be using Raptiva (efalizumab) for chronic plaque psoriasis.
unknown title 2009
-
April 8, 2009 - Uniondale, New York -- Mark & Associates, P.C., a leading nationwide personal injury law firm, applauds Genentech's decision to suspend sales of the psoriasis drug Raptiva (efalizumab) in the United States.
-
April 8, 2009 - Uniondale, New York -- Mark & Associates, P.C., a leading nationwide personal injury law firm, applauds Genentech's decision to suspend sales of the psoriasis drug Raptiva (efalizumab) in the United States.
-
FDA officials said prescribers are being asked not to initiate new Raptiva (efalizumab) treatment and begin discussions with patients using the medication on how to move to alternative psoriasis therapies.
-
Etanercept and efalizumab for the treatment of adults with psoriasis.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.